Pricing Log in Create free account

Belite Bio, Inc. Sponsored ADR (BLTE) vs Ionis Pharmaceuticals, Inc. (IONS)

Belite Bio, Inc. Sponsored ADR and Ionis Pharmaceuticals, Inc. are both Biotechnology companies. Ionis Pharmaceuticals, Inc. is the larger, with a market value of $6.5B against $5.8B — 1.1× the size. Belite Bio, Inc. Sponsored ADR has the higher net margin (0.00% vs −64.7%) and the lower return on invested capital (−9.55% vs 0.00%). Across the 13 metrics below, Belite Bio, Inc. Sponsored ADR leads on 9 and Ionis Pharmaceuticals, Inc. on 4.

Valuation

Metric BLTE IONS Biotechnology median
P/E n/m n/m 10.26
P/S n/m 7.36 9.18
P/B 7.48 14.62 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 7.05 8.98
Earnings yield (1.90%) (8.90%) (34.89%)
Free cash flow yield (1.16%) (8.83%) (24.52%)

Profitability

Metric BLTE IONS Biotechnology median
Gross margin — 98.17% 65.16%
Operating margin 0.00% (68.00%) 0.00%
Net margin 0.00% (64.66%) 0.00%
Free cash flow margin 0.00% (64.93%) 0.00%
Return on equity 0.00% (105.50%) (50.12%)
Return on assets (21.60%) (18.90%) (45.60%)
Return on invested capital (9.55%) 0.00% 0.00%

Growth

Metric BLTE IONS Biotechnology median
Revenue growth (TTM) — (7.41%) 6.26%
EPS growth (last fiscal year) (95.76%) 21.71% 29.88%
Revenue growth, 5-year CAGR — 5.29% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BLTE IONS Biotechnology median
Debt to equity 0.00 3.07 0.00
Current ratio 33.56 7.89 4.89
Net debt to EBITDA 5.88 2.39 1.01

Dividend

Metric BLTE IONS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BLTE IONS Biotechnology median
Market cap 5.77b 6.45b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack